At the virtual DTx East conference in September, five active investors with a focus on digital therapeutics discussed the market. Here are four of the topics they dug into:

• What they look for in potential investment targets
• Red flags when evaluating a digital therapeutic startup
• What startups should look for in investors
• How COVID--19 has just been a speedbump for some and created tailwinds for others
• And more...

Here are the panelists and notes from their self-introductions:

Caleb Winder, Managing Director, MemorialCare Innovation Fund

We are focused on investing in healthcare companies across the US in early Series B or later.

Chihiro Hosoya Head of Venture Management & Business Development, Rx+ Business Accelerator Astellas Pharma

Astellas is a pharmaceutical company based in Japan but we operate globally. My scope includes both digital and devices, so we are super interested in